首页> 外文OA文献 >Anti-GD2 antibody disrupts GD2:Siglec-7 interactions and synergizes with CD47 blockade to mediate tumor eradication

【2h】

Anti-GD2 antibody disrupts GD2:Siglec-7 interactions and synergizes with CD47 blockade to mediate tumor eradication

机译：抗GD2抗体破坏GD2：SIGLEC-7相互作用，并用CD47阻断协同增长以介导肿瘤根除

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Johanna Theruvath; Marie Menard; Benjamin A.H. Smith; Miles H. Linde; Garry L. Coles; Wei Wu; Louise Kiru; Alberto Delaidelli; John L. Silberstein; Allison Banuelos; Shaurya Dhingra; Elena Sotillo; Sabine Heitzeneder; Aidan Tousley; John Lattin; Peng Xu; Jing Huang; Nicole Nasholm; Guillermo Nicolas Dalton; Andy He; Tracy C. Kuo; Emma R.B. Sangalang; Jaume Pons; Amira Barkal; Rachel Brewer; Kristopher D. Marjon; Payton L. Marshall; Ricardo Fernandes; Jennifer R. Cochran; Poul H. Sorensen; Heike E. Daldrup-Link; Irving L. Weissman; Julien Sage; Ravindra Majeti; Carolyn R. Bertozzi; William A. Weiss; Crystal L. Mackall; Robbie G. Majzner;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Potent Anti-Tumor Effect Using T Cells Armed with Recombinant Anti-GD2 Bispecific Antibodies Against GD2 Positive Tumor [J] . Nakajima M., Guo H., Hoseini S. S., Pediatric blood & cancer . 2018,第Suppla2期

机译：使用具有对GD2阳性肿瘤的重组抗GD2双特异性抗体的T细胞使用T细胞的有效的抗肿瘤效应
2. Potent Anti-Tumor Effect Using T Cells Armed with Recombinant Anti-GD2 Bispecific Antibodies Against GD2 Positive Tumor [J] . Nakajima M., Guo H., Hoseini S. S., Pediatric blood & cancer . 2018,第Suppla2期

机译：使用具有对GD2阳性肿瘤的重组抗GD2双特异性抗体的T细胞使用T细胞的有效的抗肿瘤效应
3. Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors [J] . Vargas Frederick Arce, Furness Andrew J. S., Solomon Isabelle, Immunity . 2017,第4期

机译：FC优化的抗CD25耗尽肿瘤浸润的调节性T细胞，并用PD-1阻断协同增长以根除已建立的肿瘤
4. Microtubule-Depolymerizing Agents Used in ADCs Induce Anti-Tumor Immunity and Synergize with Immune Checkpoint Blocking Antibodies [C] . Philipp Muller, Kea Martin, Sebastian Theurich, PEGS . 2014

机译：ADCS中使用的微管 - 解聚剂诱导抗肿瘤免疫，并用免疫检查点阻断抗体进行协同
5. Immunological consequences of antibody-tumor antigen interactions on the development of potent anti-tumor immunity. [D] . Kim, Peter Sungwhan. 2007

机译：抗体-肿瘤抗原相互作用对有效抗肿瘤免疫力发展的免疫学后果。
6. Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2 [O] . Stanley Ly, Vivek Anand, Fouad El-Dana, 2021

机译：抗GD2抗体Dinutuximab通过靶向GD2来抑制三阴性乳腺肿瘤生长
7. Nuclear Factor Kappa B–mediated Cd47 Up-regulation Promotes Sorafenib Resistance And Its Blockade Synergizes The Effect Of Sorafenib In Hepatocellular Carcinoma In Mice [O] . Lau YT, Ching HH, Ng IOL, 2015

机译：核因子Kappa介导的Cd47上调促进索拉非尼耐药及其阻断协同索拉非尼对小鼠肝细胞癌的作用

Anti-GD2 antibody disrupts GD2:Siglec-7 interactions and synergizes with CD47 blockade to mediate tumor eradication

著录项

引文网络

相似文献

相关主题

期刊订阅